- Home
- SSYS vs AUTL Comparison
SSYS vs AUTL Comparison
Compare SSYS & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSYS | AUTL |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 654.9M | 431.2M |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SSYS | AUTL |
|---|---|---|
| Price | $7.81 | $1.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $12.33 | $8.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 03-05-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | $4.48 | $85.73 |
| Revenue Next Year | $3.23 | $70.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $7.34 | $1.11 |
| 52 Week High | $12.78 | $2.70 |
Technical Indicators
Market Signals| Indicator | SSYS | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 46.18 |
| Support Level | $7.54 | $1.27 |
| Resistance Level | $11.53 | $1.52 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 50.26 | 56.00 |
Price Performance
Historical ComparisonAbout SSYS Stratasys Ltd. (Israel)
Stratasys Ltd offers polymer-based 3D printing solutions for designers, engineers, manufacturers, dental and medical professionals, and others. Its 3D printing systems utilize the firm's patented extrusion-based FDM, inkjet-based PolyJet, powder-bed-based SAF, photopolymer-based P3, and Neo stereolithography technologies to enable the production of prototypes, tools, and manufactured goods directly from 3D CAD files or other 3D content. The company's solutions portfolio comprises 3D printing systems, consumables, software, paid parts, and professional services, allowing end-users to effectively print 3D models, tools, and parts. Geographically, it generates maximum revenue from the United States, followed by Europe, Middle East and Africa, Asia-Pacific, and other regions.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.